Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.04−0.09 (-7.96%)
Close on Nov 18, 2026Market cap $5.02MP/E –Yield –
Alzamend Neuro EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Alzamend Neuro
Alzamend Neuro has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?